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MyocyteCardiovascular disease is themain cause of death globally, accounting for over 17million deaths each year. As the
incidence of cardiovascular disease risesmarkedlywith age, the overall risk of cardiovascular disease is expected
to increase dramatically with the aging of the population such that by 2030 it could account for over 23 million
deaths per year. It is therefore vitally important to understand how the heart remodels in response to normal
aging for at least two reasons: i) to understand why the aged heart is increasingly susceptible to disease; and
ii) since it may be possible to modify treatment of disease in older adults if the underlying substrate upon
which the disease ﬁrst develops is fully understood. It is well known that age modulates cardiac function at
the level of the individual cardiomyocyte. Generally, in males, aging reduces cell shortening, which is associated
with a decrease in the amplitude of the systolic Ca2+ transient. This may arise due to a decrease in peak L-type
Ca2+ current. Sarcoplasmic reticulum (SR) Ca2+ load appears to bemaintained duringnormal aging but evidence
suggests that SR function is disrupted, such that the rate of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA)-
mediated Ca2+ removal is reduced and the properties of SR Ca2+ release in terms of Ca2+ sparks are altered.
Interestingly, Ca2+ handling is modulated by age to a lesser degree in females. Here we review how cellular
contraction is altered as a result of the aging process by considering expression levels and functional properties
of key proteins involved in controlling intracellular Ca2+. We consider how changes in both electrical properties
and intracellular Ca2+ handling may interact to modulate cardiomyocyte contraction. We also reﬂect on why
cardiovascular risk may differ between the sexes by highlighting sex-speciﬁc variation in the age-associated
remodeling process. This article is part of a Special Issue entitled CV Aging.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
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The incidence of cardiovascular disease rises dramatically with age.
Thismay not be surprising, as the aging process itself leads to important
structural and functional remodeling of the heart. There is growing
evidence that this myocardial remodeling can modify contractile func-
tion in the aging heart, even in the absence of overt systemic cardiovas-
cular disease. For example, the ability to augment contractile force in
response to stimuli that increase demand, such as exercise, declines
with age and relaxation is compromised. These changes arise, in part,
from the structural remodeling and hypertrophy that accompany the
aging process, although age-associated changes in contractile function
also reﬂect underlying modiﬁcations at the level of the individual
ventricular myocyte.
Contractile dysfunction arises as a consequence of disruption in
the sequence of events that link cardiomyocyte excitation to intra-
cellular Ca2+ release and contraction, a process known as excita-
tion–contraction (EC)-coupling. Recent evidence suggests that the
inﬂuence of age on cardiac EC-coupling differs markedly between
the sexes. Understanding how age inﬂuences the EC-coupling path-
way at the cellular level in both males and females can help us
understand whymen and women are susceptible to different cardio-
vascular diseases as they age and may help develop strategies for the
prevention and treatment of cardiovascular disease in this vulnera-
ble population. This review explores the inﬂuence of age on funda-
mental cardiomyocyte function, including myocyte excitation,
intracellular Ca2+ release and cell shortening, as well as age-
dependent changes in the ion channels and Ca2+ handling proteins
responsible for these cellular events.2. Impact of age on cardiac contractile function
Clinical studies in healthy individuals have established that aging is
associated with marked changes in cardiac structure, such as left
ventricular hypertrophy and remodeling of the extracellular matrix
[1]. Advanced age is also characterized by modiﬁcations in cardiac
function [1]. Studies of myocardial function in healthy individuals at
rest have shown that cardiac output and myocardial contractility are
not affected by age [2–6]. By contrast, the ability to augment contractile
function when demand is high during activities such as exercise is com-
promised in older adults when compared to younger individuals [1,5,6].
Aged individuals also have slower contractions and less complete relax-
ation when compared to younger people, which suggests that diastolic
function declines with age [1,6,7]. Interestingly, there is evidence that
myocardial contractility is better preserved in older women when
compared to age-matched men [8]. This observation suggests that
theremay bemale–female differences in the effect of age onmyocardial
contractile function.2.1. Myocardial contractile function in aging animal models
Various animals have been used to investigate the age-dependent
changes in contractile function seen clinically. Rats and mice exhibit a
50%mortality rate at approximately 24months of age [9], which is com-
parable to the 50% mortality rate seen in 85-year-old humans [10].
Therefore, most studies use mice or rats that are approximately 24
months of age as models of human aging and the literature reviewed
here focuses on rodents that are at least 18 months of age. Structural
changes similar to those seen in older humans, including left ventricular
hypertrophy and extracellular matrix remodeling, have been demon-
strated in agedmice [11]. While the impact of age on cardiac contractile
function at rest and during exercise has not yet been investigated in
conscious rodents, in vivo echocardiography studies in anesthetized an-
imals show that age reduces fractional shortening and ejection fraction
[12–14]. These studies also demonstrate differences in myocardial
relaxation in aged rodents, which indicates that diastolic function dete-
riorates with age [13,15]. Whether age-dependent cardiac dysfunction
differs between the sexes in rodents as it does in humans is unclear, as
these studies used males only [12,13] or the sex of the animal was not
speciﬁed [14,15].
The inﬂuence of age on cardiac contractile function also has been
explored in intact heart models. Studies in Langendorff-perfused hearts
show that left ventricular end-diastolic pressure rises with age while
peak developed pressure declines, which suggests that aged animals
develop both systolic and diastolic dysfunction [15]. Furthermore,
peak tension development is reducedwith age [16], especially at higher
heart rates [17]. Other studies showed that the maximum rate of
tension development (+dT/dt) and maximum rate of relaxation
(−dT/dt) are slowed with age [16,17]. Using isolated cardiac muscle
preparations, some studies report that there is no age-related decline
in peak tension in isolated papillary muscles or trabeculae [18,19],
while others report a reduction with age [20]. On the other hand,
there is general agreement that contraction duration is prolonged
with age, with an increase in both time-to-peak tension and half-
relaxation time [18–22]. Thus, evidence from studies in vivo, in intact
hearts and in cardiacmuscles demonstrates that contractions are small-
er and slower in the aging heart. On the other hand, whether this differs
between the sexes is unclear, as these studies used male animals only
[16,18–22] or did not specify the sex of the animal [15,17]. Together,
these observations indicate that cardiac contractile function declines
with age, at least in male animals.
2.2. Cellular contractile dysfunction in aged male animals
As contractions are initiated by a transient rise in Ca2+ in cardiac
myocytes, age-dependent changes in cardiac contractile function may
reﬂect disruptions in EC-coupling at the cellular level [23,24]. During
the action potential (AP), Ca2+ enters the cell through L-type Ca2+
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Ca2+ triggers ryanodine receptors (RyRs) to open, allowing release of
a larger amount of stored Ca2+ from the sarcoplasmic reticulum (SR).
SR Ca2+ is released in the form of discrete, subcellular units called
Ca2+ sparks that fuse to form the Ca2+ transient [25]. Ca2+ then binds
to myoﬁlaments to initiate contraction. Relaxation occurs mainly by
Ca2+ being sequestered by the sarco/endoplasmic reticulum Ca2+-
ATPase (SERCA), whose activity is modulated by its endogenous inhibi-
tor, phospholamban (PLB). Ca2+ is also removed from the cell, chieﬂy
by the Na+/Ca2+ exchanger (NCX) operating in its forward-mode
although it also can operate in the reverse direction, bringing Ca2+
into the cell in exchange for Na+ [26]. Contractile dysfunction in the
aging heartmay arise, in part, because the ability of individualmyocytes
to contract is adversely affected by the aging process.
A number of studies have investigated the impact of age on car-
diac contraction by comparing the amplitudes and time courses of
contractions, measured as unloaded cell shortening, in ventricular
myocytes isolated from young adult (2–7 months of age) and aged
(20–33 months of age) male rats and mice (Table 1). It is well known
that the aging process leads to a marked increase in the size of ventric-
ular myocytes through an increase in cardiomyocyte length, width
and area (Supplemental Table 1). This likely contributes to the age-
dependent hypertrophy seen in intact hearts [11]. Because of this age-
associated cellular hypertrophy, contractions are typically normalized
to cell length in functional studies. With this approach, there is now
convincing evidence that peak cell shortening declines with age in
male mice ([12,15,27–31] but c.f. [32,33]) and guinea pigs [34]. Many
studies also have shown similar effects in male rats [35–39], although
others report peak contraction to be unaltered during aging [40–47].
Interestingly, all studies in rats and mice that showed a decline in
peak contraction with age used rapid pacing frequencies (e.g. between
1 and 9 Hz), while those reporting no effect typically paced cells at
slow rates (e.g. ≤ 0.5 Hz), well below physiological for rodents [48].
This suggests that it is important to use cells that are challenged withTable 1
Impact of age on cardiomyocyte contraction.
Sex Component Functional
changea
Species Referencesb
Male Peak contraction ↓ Rat [35–39]
Mouse [12,15,27–31]
Guinea pig [34]
↔ Rat [40–47]
Mouse [32,33]
Time-to-peak contraction ↑ Rat [35,42,46]
Mouse [15,28,31,32]
Guinea pig [34]
↔ Rat [36,43–45,47]
Mouse [12]
↓ Mouse [33]
Relaxation rate Slowed Rat [35,37,38,43–45]
Mouse [12,15,29–32]
Guinea pig [34]
↔ Rat [36,42,46,47]
Mouse [27,28,33]
Female Peak contraction ↔ Rat [36,49–51]
Mouse [28,33]
Time-to-peak contraction ↔ Rat [36]
Mouse [28]
↓ Mouse [33]
↑ Rat [49,51]
Relaxation rate ↔ Rat [36]
Mouse [28,33]
Slowed Rat [49,51]
a Values are expressed relative to young adults (2–7 months of age for rats and mice;
1–3 months for Guinea pigs); aged rats and mice were between 20–33 months of age
and older Guinea pigs were 13–16 months.
b In some studies [15,38,39,43,45], the sex of the animals was not speciﬁed and is
assumed to be male.physiological or near-physiological pacing frequencies when investigat-
ing the impact of age on cell shortening. These observations support the
conclusion that a decline in the ability of individual cardiomyocytes to
contract contributes to the age-dependent reduction in myocardial
contractility seen in intact hearts, at least in male animals when cells
are paced at physiological rates.
To determine whether the age-dependent slowing of contraction
seen in multicellular preparations arises from slower contractions at
the level of the cardiomyocyte, time-to-peak contraction and relaxation
rates have been quantiﬁed, as summarized in Table 1. Time-to-peak con-
traction is prolongedwith age inmany studies inmale animals [15,28,31,
32,34,35,42,46], although some have found no age-dependent change
[12,36,43–46] or even a decrease [33]. Interestingly, most of these latter
studies [12,43–46] used sub-physiological pacing rates (e.g. 0.1–0.5 Hz),
which may mask age-dependent slowing of contraction that is seen at
faster rates. There also is considerable evidence that relaxation rates
are slowedwith age in cells frommale rats,mice andguinea pigs, regard-
less of pacing frequency [12,15,29–32,34,35,37,38,43–45], though some
do report no age-dependent slowing [27,28,33,36,42,46,47]. Taken to-
gether, these observations suggest that cardiomyocyte contractions are
smaller and slower in cells from agedmales when compared to younger
adults. These data from unloaded cardiomyocytes are similar to data
from multicellular preparations subjected to preload, as discussed in
Section 2.1. This suggests that age-dependent changes in contraction
are independent of preload, although additional investigation will be
required to conﬁrm this experimentally.
2.3. Contractions in myocytes from aged females
Most experimental studies of the aging heart have used male
animals, presumably under the assumption that results obtained in
older males can be extrapolated to females. However, there is
emerging evidence that the aging process affects cardiac function
rather differently in the two sexes. Although information is limited,
a few studies have evaluated contractile function in ventricular
myocytes from females (Table 1). Whether contractions are slowed
with age in females is controversial, but it is clear that peak contrac-
tions do not decline [28,33,36,49–51]. Even when cells are stimulat-
ed at relatively rapid rates (e.g. 2–4 Hz), peak contractions are not
affected by age in females [28,36,50]. As most studies in males report
a marked reduction in contraction amplitudes with age (Table 1),
these observations suggest that the aging process has distinct effects
on male and female hearts. Certainly, these data suggest that it is
essential to consider both male and female animals in experimental
studies of the aging heart.
2.4. Contractile proteins in the aging heart
Modiﬁcations in contractile function could be mediated by effects of
age on contractile proteins. To investigate this, a number of investiga-
tors have compared myoﬁlament proteins in young adult and aged
hearts. The results of these studies are summarized in Supplemental
Table 2. There is compelling evidence for an age-related shift from the
fast α myosin heavy chain (MHC) isoform to the slower β isoform in
hearts from both sexes ([51–55] but c.f. [49]). Phosphorylation of tropo-
nin I also declines with age in males and females [46,49,54]. The
predominance of the slower β-MHC isoform coupled with reduced
phosphorylation of troponin I could account for the slowing of re-
laxation reported in many studies of the aging heart (Table 1). Other
investigations have demonstrated an age-associated reduction in
myoﬁlament Ca2+ ATPase activity in male hearts [20,32,52], which is
compatible with the prolonged time-to-peak contraction seen in the
agingmale heart (Table 1). Whether myoﬁlament Ca2+ ATPase activity
also decreases with age in hearts from females has not yet been
investigated.
Table 2
Age-dependent changes in cardiomyocyte calcium transients.
Sex Component Functional
changea
Species Referencesb
Male Peak Ca2+ transient ↓ Rat [36,39]
Mouse [12,15,28–30]
↔ Rat [40,41,45]
Mouse [27,31]
↑ Mouse [32]
Time-to-peak Ca2+ transient Prolonged Rat [39,45]
Mouse [28,68]
↔ Rat [36,47]
Mouse [31–33]
Ca2+ transient decay rate Slower Rat [36,39,45]
Mouse [12,15,27,30–32,68]
↔ Rat [47]
Mouse [33]
Diastolic Ca2+ ↑ Rat [45,47]
Mouse [15,68]
↔ Rat [36]
Mouse [12,33,103]
↓ Mouse [28]
Female Peak Ca2+ transient ↔ Rat [36,49–51]
Mouse [28]
Rabbit [70]
↑ Sheep [71]
Time-to-peak Ca2+ transient ↔ Rat [36]
Mouse [28,33]
Prolonged Rat [51]
Sheep [71]
Ca2+ transient decay rate ↔ Rat [36]
Mouse [28]
Rabbit [70]
Slower Rat [49,51]
Faster Mouse [33]
Sheep [71]
Diastolic Ca2+ ↔ Rat [36]
Mouse [28,33]
Sheep [71]
a Values are expressed relative to young adults (2–7 months of age for rats and mice;
5–9 months for rabbits; 18 months for sheep); aged rats and mice were between
20–33months of age, aged rabbitswere 48–72months and older sheepwereN96months.
b In some studies [15,39,45,68], the sex of the animals was not speciﬁed and is assumed
to be male.
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As discussed in Section 2.2, contractions are initiated by an increase
in intracellular Ca2+ levels in individualmyocytes. These Ca2+ handling
processes are tightly controlled in the young adult heart and are regulat-
ed by phosphorylation through the cAMP/protein kinase A (PKA) and
Ca2+-calmodulin-dependent kinase II (CaMKII) pathways [56,57]. Care-
ful control of Ca2+ in the cardiomyocyte is crucial, as intracellular Ca2+
is required to initiate contraction but disruption of Ca2+ handling
contributes to cardiovascular diseases [58] and may predispose the
aging heart towards the development of these diseases [59].
3.1. Inﬂuence of age on Ca2+ homeostasis in ventricular myocytes from
male animals
To determine whether age-related disruptions in cardiac contrac-
tions are accompanied by parallel changes in underlying Ca2+ tran-
sients, the impact of age on Ca2+ homeostasis in ventricular myocytes
has been investigated. The results of these studies are summarized in
Table 2. There is a growing consensus that peak Ca2+ transients decline
with age in male rodents [12,15,28–30,36,39], although some report no
age-dependent change [27,31,40,41,45] and one study even found an
increase with age [32]. As with contractions, smaller Ca2+ transients
in aged myocytes are typically observed in studies that challenge cells
with rapid pacing rates [12,15,28–30,36,39], while those that report
no effect tend to use lower stimulation rates [27,40,41,45]. Thus, like
the inability of the aged human heart to augment contractile functionduring exercise (as discussed in Section 2), aged cardiomyocytes appear
less able to respond to higher rates of stimulation and thus the aged
phenotype may be unmasked at increased rate.
Since increasing rate revealed age-associated changes in contraction
and intracellular Ca2+, the effects of age observed at faster pacing rates
may be Ca2+-dependant, at least in rodents. It is well known that
CaMKII plays an important role in the response to increased stimulation
rate by phosphorylating key Ca2+ handling proteins (e.g. [60–64]). It is
therefore interesting that levels of CaMKII (δ-isoform) are reduced in
the aged male rat heart and that CaMKII-mediated phosphorylation of
key Ca2+ handling proteins (RyR, SERCA and PLB) also is reduced [65].
Thus, we might speculate that, at least in the male rat, a decrease in
CaMKII phosphorylation results in the aged heart being less able to
respond to increases in rate. Whether age inﬂuences CaMKII levels in
females is not yet known, although sex differences in CaMKII activation
have been reported in hearts from younger animals [66]. Although age
affects contractions and Ca2+ transients primarily at rapid pacing
rates in male rodents, whether similar frequency-response results
would be obtained in larger mammals is not clear. Few aging studies
have examined larger mammals (e.g. sheep, rabbits) and those that
have used female animals, where age-dependent changes are minimal.
There may be important differences in frequency-responses between
rodents and larger mammals, as rodents have much less contractile
reserve than larger species [67].
There is also good evidence that the time course of Ca2+ release is
prolonged with age in males, with many reporting an increase in
time-to-peak transient ([28,39,45,68] but c.f. [31–33,36,47]) and virtu-
ally all reporting a marked prolongation of Ca2+ transient decay with
age ([12,15,27,30–32,36,39,45,68] but c.f. [33,47]). One might predict
that slowed decay would lead to an increase in diastolic Ca2+ levels
with age in cells from male animals. Still, there is no clear consensus
onwhether diastolic Ca2+ levels are affected by age, as there is evidence
for unchanged, increased and reduced levels in cells from aged males
(Table 2). Disparate results could be due to differences in experimental
conditions between studies. Interestingly, under some circumstances
slower Ca2+ transients can actually augment contraction, as myoﬁla-
ments are exposed to Ca2+ for a longer period of time [69]. It is possible
that this effect might mask an even larger decrease in myoﬁlament
function in aged cardiomyocytes, although additional experiments will
be required to test this experimentally. While slowed decay is consis-
tent with reduced CaMKII phosphorylation of SERCA/PLB, altered pro-
tein levels also appear to be important in deﬁning this slow decay and
are discussed in Section 5.1. Taken together, these ﬁndings suggest
that smaller peak contractionswhich relaxmore slowly are attributable,
at least in part, to smaller Ca2+ transients that decay more slowly in
myocytes from males.
3.2. Ca2+ homeostasis in myocytes from aged females
Table 2 also summarizes results of several studies that have investi-
gated the impact of age on Ca2+ transients in cells from females. Unlike
males, peak Ca2+ transients are not affected by age in cardiomyocytes
from female rats, mice or rabbits [28,36,49–51,70] and Ca2+ transients
actually increase with age in female sheep [71]. This is true even when
myocytes are paced between 2 and 4 Hz [28,36]. While most studies
have found that time-to-peak transient and Ca2+ transient decay rates
are not affected by age in females ([28,36,70] but c.f. [33]), some report
that time-to-peak is prolonged and decay rates are slower in cells from
aged animals [49,51]. Interestingly, Ca2+ transient decay rates actually
increasewith age in the sheepmodel [71]. Consistentwith these results,
diastolic Ca2+ levels are not affected by age in myocytes from female
animals (Table 2). These studies indicate that age has relatively little
effect on Ca2+ transient amplitude in cardiomyocytes from female ani-
mals, which differsmarkedly from observations inmales. Still, additional
studies that explore rapid pacing rates in female myocytes could be
informative. It is also important to note that cardiomyocyte contractions
Table 4
Inﬂuence of age on sarcolemmal proteins and currents.
Sex Component Functional changea Species Referenceb
Male L-channel ↔ DHP receptor density Rat [45,89]
Mouse [31,32]
↓ DHP receptor density Hamster [91]
↔ protein Rabbit [90]
ICa-L ↓ peak ICa-L Rat [36,78]
Mouse [28]
Rabbit [90]
↔ peak ICa-L Rat [47,79]
Slowed inactivation Rat [78,79]
Mouse [28]
K+ currents ↔ ITO Rat [75]
↓ ITO, IKATP Rat [79,81,95]
↑ ITO, IK1 Rat [78,79]
NCX ↔ NCX mRNA Mouse [32]
↔ NCX protein Rat [44,82,99]
66 H.A. Feridooni et al. / Journal of Molecular and Cellular Cardiology 83 (2015) 62–72and Ca2+ transients differ between the sexes in cells from young adult
animals, with young adult females typically having smaller and slower
contractions and Ca2+ transients than age-matched males [72,73].
Thus, contractions and Ca2+ transients in myocytes from aged males
become similar to responses in females, regardless of age.
4. The inﬂuence of age on cardiac excitation
Ca2+ release from the SR is initiated by the cardiac AP, which arises
as a result of changes in permeability of the sarcolemma to Na+, Ca2+
and K+. Therefore, the effect of age on cardiac APs and underlying
ionic currents has been explored by a number of investigators.
4.1. RMP and AP conﬁguration in myocytes from aged animals
Table 3 summarizes the age-dependent changes in resting mem-
brane potential (RMP) and AP conﬁguration in studies of intact ventric-
ular muscle and isolated ventricular myocytes. Most studies used adult
(1–6 months of age) and aged (18–31 months of age) male rats. As
shown in Table 3, there is very little evidence that age inﬂuences RMP
([18,19,40,74–79] but c.f. [47,81,82]). Most studies also report that age
has no effect on the amplitude of the cardiac AP ([74,75,77,79–81] but
c.f. [76,78,82]). By contrast, there is general agreement that age causes
a prolongation in AP duration at 50% repolarization (APD50) ([18,38,
74–77,79,81] but c.f. [40,78,82]). Furthermore, virtually all investiga-
tions report an age-associated increase in AP duration at 90% repolariza-
tion (APD90) in ventricular myocyte and tissues frommale rats ([19,38,
74,76–78,80–82] but c.f. [40]). A similar pattern is seen in ventricular
myocytes from aged female sheep [71] but not rabbits [70]. Still, one
cannot directly compare APs in larger mammals such as rabbits and
sheep with those in rats, as different K+ currents are responsible for
repolarization [83]. More studies are needed to determine whether
age has similar effects on cardiac excitation in males and females. This
is important, as there is evidence for male–female differences in APD
in ventricular myocytes from young adult animals [73]. Whether such
alterations persist in aging is important, asmen andwomen are suscep-
tible to different types of arrhythmias at all ages [84,85].
The shape of the cardiac AP is inextricably linked to Ca2+ handling in
the heart. When myocytes from aged rats were stimulated with a short
‘young type’ AP, instead of their native long AP, Ca2+ transient ampli-
tude decreased while peak ICa-L increased, prompting the authors to
suggest that old rats utilize AP prolongation to sustain youthful Ca2+
regulation [86]. In a separate study in rats where intracellular Ca2+
was buffered with EGTA, AP prolongation was greater in young vs.
aged myocytes and resulted in a loss of the age-associated increase in
APD suggesting that a Ca2+-dependent process plays a part in AP pro-
longation in aging [79]. Under these circumstances, age-related changesTable 3
Impact of age on cardiac resting and action potentials.
Sex Component Functional changea Species Referenceb
Male RMP ↔ Rat [18,19,40,74–79]
↓ Rat [47]
↑ Rat [81,82]
AP amplitude ↔ Rat [74,75,77,79–81]
↑ Rat [76,78,82]
APD50 ↑ Rat [18,38,74–77,79,81]
↔ Rat [40,78,82]
APD90 ↑ Rat [19,38,74,76–78,80–82]
↔ Rat [40]
Female RMP ↔ Sheep [71]
AP amplitude ↔ Sheep [71]
APD90 ↔ Rabbit [70]
↑ Sheep [71]
a Values are expressed relative to young adults (1–8 months of age for rats; 18 months
for sheep); aged ratswere between 18–31months of age and older sheepwere N96months.
b In the study byWeisser-Thomas et al. [38] the sex of the animalswasnot speciﬁedand
is assumed to be male.in APD appear to potentiate the Ca2+ transient, which may itself act to
potentiate APD. This may not be the case for larger mammals, where
an increase in APD can attenuate SR Ca2+ release [87,88]. Prolongation
of the action potential also may help explain the age-related slowing
of the rising phase of the Ca2+ transient, as increased APD is known to
de-synchronize SR Ca2+ release [88]. Additional confocal microscopy
and imaging experiments to investigate whether aging leads to
de-synchrony of SR Ca2+ release would be of interest. Age-dependent
changes in ICa-L also may inﬂuence Ca2+ release, as discussed in
Section 4.2.
4.2. Age-associated modiﬁcations in ICa-L in ventricular myocytes
Prolongation of the AP in aging could arise from changes in ionic cur-
rents that either prolong depolarization or attenuate repolarization.
Whether Na+ currents are inﬂuenced by age in ventricular myocytes
has not yet been investigated. On the other hand, many studies have
focussed the effect of age on Ca2+ inﬂux via L-type Ca2+ channels, as
this depolarizing current is the primary trigger for SR Ca2+ release in
the heart. Whether the density of L-type Ca2+ channels is affected by
age has been investigated by quantifying either the density of
1,4-dihydropyridine (DHP) receptors or the expression of L-channel
protein in hearts from male rodents (Table 4). These studies clearly
show that L-type Ca2+ channel density and expression does not change
with age ([31,32,45,89,90] but c.f. [91]). Others have looked for evidence
of age-relatedmodiﬁcations in the amplitude and characteristics of ICa-L.
In these studies, transmembrane currents are normalized to cell capac-
itance to compensate for the age-related increase in cellmembrane area
consistently seen in ventricular myocytes (Supplemental Table 1).Mouse [12,31]
Rabbit [90]
↔ NCX activity Rat [80]
↓ NCX protein Rat [43,45,100]
Mouse [17]
↓ NCX activity Rat [101,102]
↑ forward mode current Rat [82]
Female L-Channel ↔ L-channel protein Rabbit [70]
ICa-L ↓ peak ICa-L Rat [36]
↔ peak ICa-L Mouse [28]
Rabbit [70]
Rat [94]
↑ peak ICa-L Sheep [71]
↔ inactivation Mouse [28]
K+ currents ↔ ITO, IK1, IKs Rabbit [70]
NCX ↔ NCX protein Rabbit [70]
↔ forward mode current Sheep [71]
a Values are expressed relative to young adults (2–7months of age for rats and mice;
6 months for rabbits; 4 months for hamsters; 18 months for sheep); aged rats and
mice were between 20–31 months of age, aged rabbits were 26 months, aged hamsters
were 20 months and older sheep were N96 months.
b In some studies [17,43,45], the sex of the animals was not speciﬁed and is assumed to
be male.
Table 5
Age-dependent modiﬁcations in Ca2+ sequestration.
Sex Component Functional changea Species Referenceb
Male SR Ca2+ stores ↔ SR Ca2+ content Rat [36,65]
Mouse [27,28,103]
↓ SR Ca2+ content Rat [39]
↔ calsequestrin mRNA Rat [55]
↔ calsequestrin protein Rat [39,65,82]
Mouse [32,104]
SERCA2a ↓ SERCA2a mRNA Rat [55]
↓ SERCA2a protein Rat [39,43,44,99,100]
Mouse [12,31]
↓ SERCA activity Rat [45,105,106]
Mouse [15]
↔ SERCA2a protein Rat [65]
Mouse [17,68,104]
Rabbit [90]
PLB ↔ PLB protein Rat [39,44,45,65,99]
Mouse [31,32,104]
↑ PLB protein Rat [43]
Mouse [17]
↓ PLB protein Mouse [12]
SERCA2a:PLB ↓ ratio Mouse [12,32]
Female SR Ca2+ stores ↔ SR Ca2+ content Rabbit [70]
Sheep [71]
Mouse [28]
↑ SR Ca2+ content Rat [36]
↔ calsequestrin protein Rabbit [70]
SERCA2a ↔ SERCA2a protein Rat [49]
Rabbit [70]
PLB ↔ PLB protein Rabbit [70]
a Values are expressed relative to young adults (1–12 months of age for rats and mice;
5–9 months for rabbits; 18 months for sheep); aged rats and mice were between 20–31
months of age, older aged rabbits were 48–72months and older sheep were N96months.
b In some studies [15,17,39,45,55,68], the sex of the animals was not speciﬁed and is
assumed to be male; in Howlett et al. [103] and Slack et al. [104] both males and
females were used and results were pooled.
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most have found that peak ICa-L declines with age [28,36,78,90] and all
studies report that ICa-L inactivation rate is slowed in cells from male
animals [28,78,79].
The Ca2+ chelator, EGTA, has been shown to reduce the rate of ICa-L
inactivation and normalize ICa-L inactivation between old and young
rats [79]. These authors suggest that EGTA should reduce Ca2+-
dependent inactivation and thus one possibility is that the age-
associated slowing of ICa-L inactivation is due to a decrease in Ca2+-
dependent inactivation [79]. This hypothesis is consistent with the
general reduction in Ca2+ transient amplitude seen in the aged male
heart, as discussed above. The lower peak ICa-L would result in a smaller
trigger for Ca2+-induced Ca2+ release andmay help explain the smaller
Ca2+ transients seen in cells from older males. Then again, the slower
inactivation of ICa-L could lead to prolonged Ca2+ inﬂux and increase
the time course of the Ca2+ transient. This alsowould lengthen depolar-
ization and could help explain the longer APD characteristic of the aging
male heart. Prolonged Ca2+ inﬂuxmay also act to load the aged SRwith
Ca2+ [92,93] and this effect is discussed in Section 5.1.
In contrast to males, little is known about the expression of L-type
Ca2+ channels in aged female hearts. Only one study has explored this
question and they found that L-channel protein expression was not
affected by age in hearts from female rabbits [70]. Several studies have
compared the amplitudes and characteristics of ICa-L in myocytes from
young adult and aged females (Table 4). Although one study found a de-
crease in peak ICa-L with age [36] and one showed an increase [71], most
investigations report that peak ICa-L is not affected by age in cells from
female animals [28,70,94]. Furthermore, there is no evidence that the
inactivation rate of ICa-L is slowed by age in female cells [28]. This result
is consistentwith the lack of change in Ca2+ transient amplitude in aged
females and thus presumably unaltered Ca2+-dependent inactivation.
Together, these ﬁndings suggest that age has a marked effect on ICa-L
in cells from males, but little impact on this current in females.
4.3. Repolarizing currents in myocytes from aged animals
Whether an age-related decrease in repolarizing K+ currents con-
tributes to the longer APs seen in the aging male heart is controversial.
Some studies report that peak transient outward current (ITO) declines
with age [79,95], while others report no change or even an increase in
rat ventricular myocytes [75,78]. As ITO plays a major role in repolariza-
tion in the rat ventricle [83], a decrease in themagnitude of this current
would be expected to cause a marked prolongation in APD. Why this is
not seen in all studies is unclear. There is evidence that the inward rec-
tiﬁer K+ current (IK1) increases with age [79], although this would be
expected to cause faster repolarization [96]. Interestingly, a recent
study demonstrated that the ATP-sensitive K+ current (IKATP) declines
with age [81]. IKATP is activated by falling ATP levels during metabolic
stress such as ischemia and this leads to profound shortening of the car-
diac AP [83], an effect thought to minimize Ca2+ overload in ischemia
[97]. A reduction in IKATP in the aging heart suggests that the ability to
limit Ca2+ overload in ischemia may be compromised, though this
would not explain prolongation of the APD in the absence of ischemia.
The only study of K+ currents in aging females used rabbits, where
the slow delayed rectiﬁer K+ current (IKs) is a major repolarizing
inﬂuence [83]. Results showed that age had no effect on IKs, IK1 or ITO
[70], which is consistent with reports that APD is not affected by age
in female rabbits [70].
4.4. Impact of age on NCX
The electrogenic NCX primarily operates to remove one Ca2+ from
the cell in exchange for three Na+, which generates an inward current
that helps maintain the plateau of the cardiac AP [98]. Whether NCX
is modiﬁed by age has been investigated with both molecular and
functional approaches (Table 4). While most laboratories report noage-dependent change in mRNA levels, protein expression or activity
of the NCX in the male heart [12,31,32,44,80,82,90,99], others report a
reduction [17,43,45,100–102]. Only one study has investigated NCX
protein expression in the female heart and found no age-dependent
change [70], so additional work in this area could be important.
Although there is no evidence that intracellular Na+ levels vary with
age in males [80], functional studies have found that forward-mode
NCX currents are enhanced in cells from aged male rats [82]. This
depolarizing NCX current could contribute to the prolongation of the
APD seen in myocytes from aged male rats. By contrast, there is no
evidence that NCX currents are affected by age in female sheep, so
enhanced inward NCX current is unlikely to contribute to prolongation
of APD in this model [71].
5. Ca2+ sequestration and removal mechanisms in the aging heart
Given the critical role of the SR in intracellular Ca2+ release and
reuptake, the inﬂuence of age on SR Ca2+ content and SR Ca2+ handling
proteins has been the subject of extensive investigation. As with most
studies of aging, the focus has been on hearts and myocytes from male
animals.
5.1. SR Ca2+ uptake and SR Ca2+ content in myocytes from aged males
Table 5 summarizes the results of studies that have investigated the
impact of age on processes involved in SR Ca2+ sequestration. There is
virtually unanimous agreement that SR Ca2+ content is unaffected by
age in males ([27,28,36,65,103] but c.f. [39]). Furthermore, mRNA and
protein levels of the major SR Ca2+ binding protein, calsequestrin, are
not inﬂuenced by age [32,39,55,65,82,104]. By contrast, there is emerg-
ing consensus that SERCA2a mRNA, protein and activity levels decline
markedly with age in males [12,15,31,39,43–45,55,99,100,105,106],
with a few studies reporting no change [17,65,68,90,104]. A decrease
Table 6
Sr Ca2+ release mechanisms in the aging heart.
Sex Component Functional changea Species Referenceb
Male RyR2 ↔ RyR2 protein Rat [39,65,99,105]
Mouse [31,32]
↓ RyR2 protein Rat [100]
Ca2+ sparks ↑ frequency Rat [39]
Mouse [103]
↓ duration Rat [39]
Mouse [103]
↓ amplitude Rat [39]
↔ amplitude Mouse [103]
↓width Rat [39]
↔width Mouse [103]
Female RyR2 ↔ RyR2 protein Rabbit [70]
Ca2+ sparks ↑ frequency Rat [94]
↔ frequency Rabbit [70]
↓ duration Rat [94]
↓ amplitude Rabbit [70]
Rat [94]
↓width Rabbit [70]
Rat [94]
a Values are expressed relative to young adults (3–9months of age for rats and mice;
5–9 months for rabbits; 18 months for sheep); aged rats and mice were between 24–28
months of age, older aged rabbits were 48–72months and older sheepwere N96months.
b In studies by Zhu et al. [39] the sex of the animals was not speciﬁed and is assumed to
be male; Howlett et al. [103] pooled cells from males and females.
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expected to reduce the rate of Ca2+ uptake by the SR. This could account
for the slowing of Ca2+ transient decay and prolonged relaxation rates
characteristic of cardiomyocytes from older males (Tables 1 & 2). Not
only do SERCA2a levels decline with age, but levels of its endogenous
inhibitor, PLB, are either unchanged or actually rise ([17,31,32,39,
43–45,65,99,104] but c.f. [12]). This would be expected to cause a
decrease in the SERCA2a:PLB ratio with age, as recently demonstrated
experimentally [12,32]. Reduced SERCA2a protein expression and
lower SERCA2a:PLB ratio levels would slow SR Ca2+ uptake, which
could explain the prolonged Ca2+ transient decay and slow relaxation
characteristic of the aging male heart.
5.2. SR Ca2+ stores in cells from aged female animals
Comparatively, few studies have explored the inﬂuence of age on SR
Ca2+ stores or SR Ca2+ handling proteins in the female heart (Table 5).
Results of these investigations have shown that SR Ca2+ content is
unaffected by age in rabbit, sheep and mouse models [28,70,71] but in-
creases with age in the rat [36]. Furthermore, there is no age-dependent
change in the expression of the major SR Ca2+ binding protein,
calsequestrin, in the aged female heart [70]. Two studies have compared
SERCA2a protein levels in young adult and aged females. They found no
effect of age on SERCA2a expression levels in hearts from female rats
and rabbits [49,70]. Furthermore, age has no effect on PLB expression
levels in the female heart [70]. Together, these ﬁndings are consistent
with previous reports that age has no impact on Ca2+ transient decay
rates in female cardiomyocytes, although more studies of SR function
and regulation in aged females are warranted.
5.3. Functional consequences of age-related changes in the SR
Along with SERCA, NCX plays a key role in decay of the Ca2+
transient because it removes Ca2+ from the cell on a beat-to-beat
basis. As described earlier (Table 5), there is little agreement onwhether
NCX expression or activity is modiﬁed by age in themale heart and few
studies have addressed this question in females. Functional studies have
shown that Ca2+ removal by NCX is increased by age in myocytes from
males [82]. This would be expected to speed decay of the Ca2+ transient
rather than slow it, although increased removal by NCX could be coun-
tered by the age-dependent decrease in SR Ca2+ uptake by SERCA. By
contrast, Ca2+ removal by NCX is not affected by age in females [71],
which is consistent with reports that Ca2+ transient decay is un-
changed. Whether age-dependent alterations in NCX expression and/
or activity inﬂuence Ca2+ inﬂux via reverse-mode NCX in aging has
not yet been investigated. The direction of NCX depends upon themem-
brane potential and the concentration gradients for Na+ and Ca2+,
which are inﬂuenced by factors such as stimulation rate, external
Ca2+ concentrations and species [48,107]. Thus, it may be difﬁcult to
compare results of functional studies of NCX conducted in different
species under diverse experimental conditions.
Taken together, these data support the view that SERCA2a activity is
reduced in hearts from agingmale animals (Table 5). Onemight expect
this to reduce SR Ca2+ content, but there is virtually no evidence that SR
Ca2+ content changes with age in males. It is possible that SERCA activ-
ity is only impaired in aged cells at baseline and increasing Ca2+ by
more rapid pacing may activate SERCA to normal levels via CAMKII
(e.g. [60]). However, as discussed above, CAMKII (δ-isoform) levels
and phosphorylation of PLB is decreased in the aged male heart which
may affect responsiveness to increased rate. Alternatively, SR Ca2+
stores in males may be maintained by: i) reduced peak ICa-L, whereby
a smaller trigger results in reduced Ca2+ release from the SR and less
Ca2+ being lost from the cell [93] and ii) slower inactivation of ICa-L, if
this results in increasedCa2+ loading via ICa-L (and this remains to be test-
ed). As such, applying a short AP to old rat cells augments peak ICa-L,
reduces ICa-L integral and decreases SR Ca2+ content [86], consistentwith a smaller peak and larger integral of ICa-L in the aged heart having
apositive effect on SRCa2+ load. Fewstudies have examined SERCA2a ex-
pression in older females, but those that have found no age-dependent
decline. This is compatible with reports that SR Ca2+ content does not
change (Table 5), although why SR Ca2+ content increases with age in
female rats is not yet clear.
6. SR Ca2+ release mechanisms in the aging heart
As SERCA-mediated Ca2+ uptake declines with age while SR Ca2+
content is unaffected, some laboratories have investigated whether
age affects Ca2+ sparks that act to regulate SR Ca2+ content. Still, only
a few studies have examined mechanisms involved in SR Ca2+ release
in hearts and myocytes from young adult and aged animals.
6.1. RyRs and Ca2+ sparks in the aging heart
One approach to explore the inﬂuence of age on SR Ca2+ release
mechanisms has been to compare the density of SR Ca2+ release
channels (RyR2) (Table 6). There is virtually unanimous agreement
that age has no effect on expression of RyR2 protein in hearts from
males and females ([31,32,39,65,70,99,105] but c.f. [100]). These data
strongly suggest that the expression of SR Ca2+ release channels is not
modiﬁed by age.
Ca2+ is released from the SR in the form of Ca2+ sparks that fuse to
create the Ca2+ transient [25]. Therefore, some investigators have char-
acterized spontaneous Ca2+ sparks to probe Ca2+ release mechanisms
in aging heart (Table 6). Most studies have shown that Ca2+ spark du-
ration, amplitude and width decline with age in both sexes [39,70,94],
although one study found that only spark duration decreases with age
[103]. There also is growing evidence that spontaneous spark frequency
increases with age regardless of the sex of the animal ([39,94,103] but
c.f. [70]). As elevated SR Ca2+ content increases the frequency of spon-
taneous Ca2+ sparks [108], the higher spark frequency in older females
could be due to increased SR Ca2+ [36]. On the other hand, most studies
in males and females have found that SR content is unaffected by age
[27,28,36,65,70,71,103]. At present the reasons for the age-dependent
decrease in the average size of Ca2+ sparks and increase in spark
frequency are not clear but could involve post-translational modiﬁca-
tions of RyRs as discussed in Section 6.2 below.
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mechanisms
As spark properties are modiﬁed by phosphorylation via the cAMP/
PKA and CaMKII pathways [109–111], it is possible that age-dependent
modiﬁcations in Ca2+ sparks are mediated by these routes. Indeed,
cAMP levels are lower in ventricular myocytes from aged male rats
compared to young adult controls [41]. While this could account for
smaller Ca2+ sparks in the aging heart, it would not explain the increase
in spark frequency with age ([39,103] but c.f. [70]). Age-associated
changes in the CaMKII pathway also may be implicated, as CaMKII is
activated by intracellular Ca2+, which is modiﬁed by age in older
males (Table 2). Furthermore, CaMKII δ protein expression declines in
hearts from aged males and phosphorylation of RyR by CaMKII is
reduced [65], which is compatible with smaller Ca2+ sparks in the
aging heart [111]. Additional studies that explore these and other path-
ways involved in post-translational modiﬁcations of Ca2+ release
mechanisms in the aging heart could be informative.
Several conclusions can be drawn from these studies of SR Ca2+
release mechanisms. The data presented above suggest that a decrease
in the size of individual Ca2+ sparks is characteristic of the aging heart, re-
gardless of the sex of the animal. On the other hand, spark frequency is in-
creased with age. It is possible that the age-related decrease in spark size
may offset the higher spark frequency to maintain SR Ca2+ load in the
aging heart. Still, these smaller Ca2+ release units in conjunction with
reduced peak ICa-L may combine to produce smaller Ca2+ transients in
the aging male heart. By contrast, there is no change in peak ICa-L in
aging female hearts, which may partially compensate for smaller Ca2+
release units and result in little or no attenuation of peak SR Ca2+ release.RyR2
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Fig. 1. Age-related changes in cardiac EC-coupling in isolated ventricular myocytes. A schemati
mechanisms in cardiomyocytes frommale animals. 1. There is a decrease in peak ICa-L and a slow
spark frequency increaseswith agewhile the size of individual Ca2+ sparks declines. 3. SR Ca2+
cardiomyocytes from aged males. 5. Age-related changes in myoﬁlament proteins include a sh
myoﬁlament Ca2+ ATPase activity. 6. Ca2+ uptake by SERCA2a is slower in myocytes from age
a reduction in the SERCA2a:PLB ratio. 7. There is no clear pattern of change in NCX expression
to these marked age-dependent changes in EC-coupling in the male heart, there is little eviden7. Conclusions
Based on the evidence reviewed here, several conclusions can be
made about the inﬂuence of age on cardiac EC-coupling mechanisms,
as illustrated in Fig. 1. Contractions and Ca2+ transients are smaller
and slower in ventricularmyocytes from agedmales compared to youn-
ger animals. The decrease in peak contractions and Ca2+ transients
arises as a consequence of smaller peak ICa-L and a reduction in the
size of Ca2+ sparks in aging cardiomyocytes. Prolongation in the time-
to-peak contraction likely reﬂects, at least in part, a decrease in myoﬁl-
ament Ca2+ ATPase activity in the aging heart. Relaxation is slowed due
to an age-related shift to the slower β-MHC isoform, reduced phosphor-
ylation of troponin I and slower Ca2+ transient decay. The slower rate of
decay of the Ca2+ transient in aged cardiomyocytes is due to prolonga-
tion of the APD as well as a reduction in the SERCA2a:PLB ratio. In con-
trast to ﬁndings in males, there is little evidence that EC-coupling
mechanisms are affected by age in cardiomyocytes from females. Peak
contractions and Ca2+ transients are similar and there is little evidence
for a reduction in peak ICa-L. Some studies suggest that APD and Ca2+
transient decay are prolonged in females, and the frequency of Ca2+
sparks increases with age, but spark size declines. These ﬁndings
demonstrate that the aging process inﬂuences critical mechanisms
involved in cardiac EC-coupling, although age-dependent remodeling
differs between the sexes.
Reasons for male–female differences in cardiac aging are not yet
known, but several factors may contribute. It is possible that age-
dependent changes in sex steroid hormone levels contribute to the
effects of age on cardiac EC-coupling mechanisms. It is well known
that cardiomyocytes contain receptors for estrogen, progesterone and©www.maritimemedicaldesign.com
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ing of inactivation of this current with age. 2. There is no change in RyR2 density, but Ca2+
content is not affected by age. 4. Ca2+ transients and contractions are smaller and slower in
ift to the slower β-MHC isoform, reduced troponin I phosphorylation and a reduction in
d animals when compared to younger adults, due to reduced expression of SERCA2a and
in the aging male heart, although Ca2+ extrusion by NCX may be enhanced. In contrast
ce that age affects EC-coupling mechanisms in the female heart.
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shown that removal of the ovaries increases cellular Ca2+ transients
and contractions [73]. Although less information is available, removal
of the testes in young adult males prolongs contraction time in isolated
myocytes [73]. These data suggest that sex steroid hormones can inﬂu-
ence cardiomyocyte function. Interestingly, there is evidence that sex
hormone levels decline with age in rodents as in humans. Female rats
and mice undergo reproductive senescence and become anestrous
(loss of the estrous cycle) between the ages of 12 to 18months, depend-
ing upon the speciﬁc animal strain [112]. This is accompanied by a de-
cline in circulating levels of estrogen and progesterone [113,114].
Similarly, testosterone levels decrease with age (N20 months) in
male rodents in conjunction with a decline in fertility, while estrogen
levels rise [115,116]. Thus, the effect of sex steroid hormones on
cardiomyocytes may contribute to the age-related changes outlined in
this review. It is also important to emphasize that, compared to males,
relatively few studies have actually investigated the inﬂuence of age
on cardiac EC-coupling mechanisms in female animals and many that
have examined females have not evaluated age-matched males. More
studies that investigate aging in both male and female models at the
cellular, organ and intact animal levels could be illuminating.
8. Implications
As our population ages, the incidence of cardiovascular disease rises
dramatically in both sexes, though there are important male–female
differences in incidence, prevalence, presentation and outcomes associ-
ated with cardiovascular diseases [117,118]. For example, the incidence
and prevalence of ischemic heart disease, the most common form of
CVD, is higher in men than in women [118,119], although it rises mark-
edly in women after menopause [120]. Paradoxically, while women
with ischemic heart disease have less obstructive coronary artery
disease than do men, they have more ischemia and higher mortality
[121–123]. Although heart failure also occurs less often in women,
their overall mortality rate is higher [117,124]. Men tend to develop
heart failure with reduced ejection fraction, characterized by left
ventricular dilatation and reducedwall thickness [125,126]. By contrast,
women develop heart failure with preserved ejection fraction (HFpEF),
characterized by normal left ventricular cavity size, increased wall
thickness and diastolic dysfunction [125–127].
The observation that there are male–female differences in the way
the heart ages at the cellular level has important clinical implications,
since modiﬁcations in myocardial Ca2+ homeostasis and cardiac
contraction are certain to interact with disease in the aging heart. For
example, the observation that contractions and Ca2+ transients decline
with age in males but not females may help explain why heart failure
with reduced ejection fraction tends to occur in older men, while
HFpEF is common in older women [126]. Furthermore, intracellular
Ca2+ dysregulation is implicated in the pathogenesis of diseases such
as myocardial ischemia and arrhythmias [128], where male–female
differences are well known [118]. An increase in our understanding of
the cellular mechanisms involved in the effect of age on both male
and female hearts may help us understand why men and women are
susceptible to different cardiovascular diseases as they age and may
ultimately help identify new targets for intervention in the treatment
of these diseases in both men and women.
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